Miconazole

{{Short description|Chemical compound}}

{{Use dmy dates|date=September 2024}}

{{cs1 config |name-list-style=vanc |display-authors=6}}

{{Infobox drug

| Watchedfields = changed

| verifiedrevid = 461740624

| image = Miconazole.svg

| image_class = skin-invert-image

| width = 200

| alt =

| image2 = Miconazole ball-and-stick.png

| image_class2 = bg-transparent

| width2 = 200

| alt2 =

| chirality = Racemic mixture

| tradename = Monistat, others

| Drugs.com = {{drugs.com|monograph|miconazole}}

| MedlinePlus = a601203

| DailyMedID = Miconazole

| pregnancy_AU =

| pregnancy_AU_comment =

| pregnancy_category =

| routes_of_administration = Topical, vaginal, sublabial

| ATC_prefix = A01

| ATC_suffix = AB09

| ATC_supplemental = {{ATC|A07|AC01}} {{ATC|D01|AC02}} {{ATC|G01|AF04}} {{ATC|J02|AB01}} {{ATC|S02|AA13}}

| legal_AU = S2

| legal_AU_comment = Schedule 2 for topical formulations, schedule 3 for vaginal use and for oral candidiasis, otherwise schedule 4{{citation needed|date=June 2023}}

| legal_CA =

| legal_UK = POM

| legal_US = OTC

| legal_US_comment = / Rx-only{{cite web | title=Oravig- miconazole tablet | website=DailyMed | date=1 January 2022 | url=https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=dc2427ff-e566-4b48-b289-9e51c011250a | access-date=20 June 2023 | archive-date=14 August 2022 | archive-url=https://web.archive.org/web/20220814225102/https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=dc2427ff-e566-4b48-b289-9e51c011250a | url-status=live }}

| bioavailability = <1% after application to the skin

| protein_bound = 88.2%

| metabolism = CYP3A4

| elimination_half-life = 20–25 hrs

| excretion = Mainly feces

| CAS_number_Ref = {{cascite|correct|??}}

| CAS_number = 22916-47-8

| PubChem = 4189

| IUPHAR_ligand = 2449

| DrugBank_Ref = {{drugbankcite|correct|drugbank}}

| DrugBank = DB01110

| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}

| ChemSpiderID = 4044

| UNII_Ref = {{fdacite|correct|FDA}}

| UNII = 7NNO0D7S5M

| KEGG_Ref = {{keggcite|correct|kegg}}

| KEGG = D00416

| ChEBI_Ref = {{ebicite|correct|EBI}}

| ChEBI = 6923

| ChEMBL_Ref = {{ebicite|correct|EBI}}

| ChEMBL = 91

| synonyms =

| IUPAC_name = (RS)-1-(2-(2,4-Dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl)-1H-imidazole

| C=18 | H=14 | Cl=4 | N=2 | O=1

| SMILES = Clc1cc(Cl)ccc1C(Cn2ccnc2)OCc3ccc(Cl)cc3Cl

| StdInChI_Ref = {{stdinchicite|correct|chemspider}}

| StdInChI = 1S/C18H14Cl4N2O/c19-13-2-1-12(16(21)7-13)10-25-18(9-24-6-5-23-11-24)15-4-3-14(20)8-17(15)22/h1-8,11,18H,9-10H2

| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}

| StdInChIKey = BYBLEWFAAKGYCD-UHFFFAOYSA-N

}}

Miconazole, sold under the brand name Monistat among others, is an antifungal medication used to treat ring worm, pityriasis versicolor, and yeast infections of the skin or vagina. It is used for ring worm of the body, groin (jock itch), and feet (athlete's foot). It is applied to the skin or vagina as a cream or ointment.{{cite web|title=Miconazole Nitrate|url=https://www.drugs.com/monograph/miconazole-nitrate.html|publisher=The American Society of Health-System Pharmacists|access-date=8 December 2016|url-status=live|archive-url=https://web.archive.org/web/20161221013013/https://www.drugs.com/monograph/miconazole-nitrate.html|archive-date=21 December 2016}}{{cite web | title=Miconazole Monograph for Professionals | website=Drugs.com | date=22 July 2022 | url=https://www.drugs.com/monograph/miconazole.html | access-date=20 June 2023 | archive-date=21 September 2022 | archive-url=https://web.archive.org/web/20220921191831/https://www.drugs.com/monograph/miconazole.html | url-status=live }}

Common side effects include itchiness or irritation of the area in which it was applied. Use in pregnancy is believed to be safe for the baby.{{cite book| vauthors = Hamilton R |title=Tarascon Pocket Pharmacopoeia 2015 Deluxe Lab-Coat Edition |date=2015 |publisher=Jones & Bartlett Learning |isbn=9781284057560 |page=180 }} Miconazole is in the imidazole family of medications. It works by decreasing the ability of fungi to make ergosterol, an important part of their cell membrane.

Miconazole was patented in 1968 and approved for medical use in 1971.{{cite book| vauthors = Fischer J, Ganellin CR |title=Analogue-based Drug Discovery|date=2006|publisher=John Wiley & Sons|isbn=9783527607495|page=502|url=https://books.google.com/books?id=FjKfqkaKkAAC&pg=PA502|url-status=live|archive-url=https://web.archive.org/web/20161220144314/https://books.google.ca/books?id=FjKfqkaKkAAC&pg=PA502|archive-date=2016-12-20}} It is on the World Health Organization's List of Essential Medicines.{{cite book | vauthors = ((World Health Organization)) | title = The selection and use of essential medicines 2023: web annex A: World Health Organization model list of essential medicines: 23rd list (2023) | year = 2023 | hdl = 10665/371090 | author-link = World Health Organization | publisher = World Health Organization | location = Geneva | id = WHO/MHP/HPS/EML/2023.02 | hdl-access=free }} It is available as a generic medication.

Medical uses

Miconazole is used externally for the treatment of ringworm, jock itch, and athlete's foot. Internal application is used for oral candidiasis or vaginal thrush (yeast infection).

Side effects

Miconazole is generally well tolerated. The oral gel can cause dry mouth, nausea and an unpleasant taste in about 1–10% of people. Anaphylactic reactions are rare. The drug prolongs the QT interval.

Interactions

Miconazole is partly absorbed in the intestinal tract when used orally, as with the oral gel, and possibly when used vaginally.British National Formulary '45' March 2003 This can lead to increased concentrations of drugs that are metabolized by the liver enzymes CYP3A4 and CYP2C9, because miconazole inhibits these enzymes. Such interactions occur for example with anticoagulants of the warfarin type, phenytoin, some newer atypical antipsychotics, ciclosporin, and most statins used to treat hypercholesterolemia. These interactions are not relevant for miconazole that is applied to the skin.

Contraindications

Miconazole is contraindicated for people who use certain drugs that are metabolized by CYP3A4, for the reasons mentioned above:

Pharmacology

=Mechanism of action=

Miconazole inhibits the fungal enzyme 14α-sterol demethylase, resulting in a reduced production of ergosterol.{{cite journal | vauthors = Becher R, Wirsel SG | title = Fungal cytochrome P450 sterol 14α-demethylase (CYP51) and azole resistance in plant and human pathogens | journal = Applied Microbiology and Biotechnology | volume = 95 | issue = 4 | pages = 825–840 | date = August 2012 | pmid = 22684327 | doi = 10.1007/s00253-012-4195-9 | s2cid = 17688962 }} In addition to its antifungal actions, miconazole, similarly to ketoconazole, is known to act as an antagonist of the glucocorticoid receptor.{{cite journal | vauthors = Duret C, Daujat-Chavanieu M, Pascussi JM, Pichard-Garcia L, Balaguer P, Fabre JM, Vilarem MJ, Maurel P, Gerbal-Chaloin S | display-authors = 6 | title = Ketoconazole and miconazole are antagonists of the human glucocorticoid receptor: consequences on the expression and function of the constitutive androstane receptor and the pregnane X receptor | journal = Molecular Pharmacology | volume = 70 | issue = 1 | pages = 329–339 | date = July 2006 | pmid = 16608920 | doi = 10.1124/mol.105.022046 | s2cid = 21455699 }}

=Pharmacokinetics=

After application to the skin, miconazole can be measured in the skin for up to four days, but less than 1% is absorbed into the bloodstream. When applied to the oral mucosa (and possibly also for vaginal use), it is significantly absorbed. In the bloodstream, 88.2% are bound to plasma proteins and 10.6% to blood cells. The substance is partly metabolized via the liver enzyme CYP3A4 and mainly eliminated via the faeces.{{cite book|title=Austria-Codex| veditors = Haberfeld H |at=Daktarin 2%-Creme|publisher=Österreichischer Apothekerverlag|location=Vienna|year=2019|language=de}}{{cite book|title=Austria-Codex| veditors = Haberfeld H |at=Daktarin 2%-orales Gel|publisher=Österreichischer Apothekerverlag|location=Vienna|year=2020|language=de}}

Chemistry

The solubilities of miconazole nitrate powder are 0.03% in water, 0.76% in ethanol and up to 4% in acetic acid.{{cite patent | inventor = Thaler I, Strauss R | country = US | number = 5461068 | title = Imidazole derivative tincture and method of manufacture | assign1 = Current Assignee Corwood Laboratories Inc | assign2 = Bausch Health Companies Inc | gdate = 24 October 1995 | postscript = . }} Miconazole crystallises as colourless prisms in the monoclinic space group P21/c.{{cite journal | vauthors = Kaspiaruk H, Chęcińska L | title = A comparison of three crystalline forms of miconazole: solvent-free, ethanol monosolvate and hemihydrate | journal = Acta Crystallographica Section C | volume = 78 | issue = Pt 6 | pages = 343–350 | date = June 2022 | pmid = 35662134 | doi = 10.1107/S2053229622004909 | s2cid = 248839249 }}

Other uses

Miconazole is also used in Ektachrome film developing in the final rinse of the Kodak E-6 process and similar Fuji CR-56 process,{{citation needed|date=June 2023}} replacing formaldehyde.{{cite web | title=Kodak Chemicals: Process E-6 Publication: Z-119 | website=Kodak | date=8 October 1999 | url=http://www.kodak.com/global/en/service/Zmanuals/z119.shtml | archive-url=https://web.archive.org/web/20070715005022/http://www.kodak.com/global/en/service/Zmanuals/z119.shtml | archive-date=15 July 2007 | url-status=dead | access-date=20 June 2023}}{{cite web | title=Kodak Chemicals: Q-LAB Process Control Handbook: Publication Z-6 | website=Kodak | date=1 November 2004 | url=http://www.kodak.com/global/en/service/Zmanuals/z6.shtml | archive-url=https://web.archive.org/web/20070207080023/http://www.kodak.com/global/en/service/Zmanuals/z6.shtml | archive-date=7 February 2007 | url-status=dead | access-date=20 June 2023}} Fuji Hunt also includes miconazole as a final rinse additive in their formulation of the C-41RA rapid access color negative developing process.{{citation needed|date=December 2022}}

Brands and formulations

File:Miconazol.jpg

Oral treatment: (brand names Daktarin in UK, Fungimin Oral Gel in Bangladesh):{{citation needed|date=December 2022}}

In 2010, the US Food and Drug Administration approved Oravig (miconazole) buccal tablets for the local treatment of oropharyngeal candidiasis, more commonly known as thrush, in adults and children age 16 and older.

External skin treatment (brand names Desenex and Zeasorb in US and Canada, Micatin, Monistat-Derm, Daktarin in India, UK, Australia, Belgium and the Philippines, Daktar in Norway, Fungidal in Bangladesh, Decocort in Malaysia){{citation needed|date=December 2022}} (Note that Desenex originally contained not miconazole, but rather the fungistatic agents, undecylenic acid and zinc undecylenate, which were in the foot powder developed by the US government for troops during WWII.{{Cite web |title=History |url=https://achh.army.mil/history/book-wwii-communicablediseasesv5-chapter7/ |access-date=2024-03-03 |website=achh.army.mil |language=en |archive-date=2024-03-03 |archive-url=https://web.archive.org/web/20240303214812/https://achh.army.mil/history/book-wwii-communicablediseasesv5-chapter7/ |url-status=live }})

Vaginal treatment (brand names Miconazex, Monistat, Femizol or Gyno-Daktarin in UK):{{citation needed|date=December 2022}}

{{clear}}

In Japan, Mochida Healthcare, a subsidiary of Mochida Pharmaceutical, produces a line of body soaps and shampoo under the brand name Collage (コラージュ) that contain miconazole nitrate as their main ingredient.{{Cite web|title=Mochida Pharmaceutical Co., list of product ingredients|url=https://hc.mochida.co.jp/products/ingredients/list.html|access-date=2024-08-21|website=hc.mochida.co.jp|language=ja}}

References